3 “Strong Buy” Biotech Stocks That Can ...

3 “Strong Buy” Biotech Stocks That Can ...
Images may be subject to copyright. View source page

[Motley Fool Australia] The Mesoblast limited (ASX:MSB) share price is in a trading halt on Thursday pending the release of a major announcement... Why the Mesoblast (ASX:MSB) share price is in a trading halt ... View more

[Stockhead] Mesoblast is in a trading halt, but doesn't expect to announce the FDA's decision on Ryoncil until Monday; Approval of the stem cell treatment to treat pediatric ... Mesoblast now expects to release Ryoncil ruling on Monday ... View more

[The Australian Financial Review] The Australian sharemarket recovers most of Wednesday's losses on hopes for US stimulus and as rising iron ore prices lift big miners. CBA's deferred loans ... ASX up 1.5pc; Reliance soars 12pc; Mesoblast halted ... View more

[The Sydney Morning Herald] The Australian sharemarket added 37 points in the space of 10 minutes to extend gains in late morning trade. The benchmark index was up 1.5 per cent and ... Late morning surge pushes ASX 1.5% higher; Gains for Rio, BHP ... View more

[The West Australian] Investors have been excited by the earning potential, as the US has no approved therapy for children. Mesoblast surges on cusp of US approval ... View more

[The Sydney Morning Herald] Stem cell treatment producer Mesoblast has recorded a significant win after the US FDA's Oncologic Drugs Advisory Committee voted in favour of its flagship ... Mesoblast rebounds 40 per cent after US regulator approval ... View more

[The Australian Financial Review] Mesoblast has scored a win in marketing its stem cell therapy drug in the US after a verdict was delivered about 7am AEST. Mesoblast scores US regulatory breakthrough ... View more

[The Australian Financial Review] Australian shares open modestly higher as banks and miners pace gains. Reserve Bank governor Philip Lowe expects the Victorian lockdowns will see a 2 ... ASX rises; RBA hasn't ruled out negative rates; Mesoblast soars ... View more

[Motley Fool] The Australian stem-cell company will face some pointed questions from regulators about how it manufactures stem cells. Mesoblast Plunges as FDA Questions Cell-Therapy Manufacturing ... View more

[The Sydney Morning Herald] The stem cell treatment maker is under pressure as it faces a crucial test to get its flagship drug approved by the US Food and Drug Administration. Mesoblast plunges 30 per cent ahead of milestone meeting ... View more

[Business News Australia] Before pivoting to find a treatment for critically ill COVID-19 patients suffering from severe acute respiratory distress syndrome (ARDS), Mesoblast's (ASX: MSB, ... FDA throws wet blanket on Mesoblast's treatment for bone marrow ... View more

[The Australian Financial Review] The US regulator has more questions for Mesoblast over its application to market a stem cell treatment for an inflammatory condition in children. Mesoblast dives on FDA reports ... View more

[Yahoo Finance] Head back to Thursday's market close and shares of drug maker Sorrento Therapeutics (SRNE) were trading for $2.62, each. As of this writing, the stock is ... Sorrento (SRNE) Stock Is up 140% in Two Days. How Much Higher ... View more

[Motley Fool] Sorrento's shares are continuing their surge from last Friday. Here's why. Why Sorrento Therapeutics Stock Is on Fire Today ... View more

[Investorplace.com] Sorrento Therapeutics (SRNE) news for Friday concerning a possible cure for the novel coronavirus has SRNE stock soaring. Sorrento Therapeutics News: SRNE Stock Skyrockets 172% on ... View more

[Business Insider] Shares of Sorrento Therapeutics spiked as much as 244% on Friday after the company claimed an antibody it's developing showed 100% inhibit... Sorrento Therapeutics skyrockets 244% after claiming a ... View more

[Motley Fool] The COVID-19 pandemic has been a major catalyst for these three biotech stocks. Inovio Pharmaceuticals, Mesoblast, and Moderna: Are These Red ... View more

Tags

Similar Images and Videos

Sorrento Therapeutics stock (SRNE) at ...

Sorrento Therapeutics stock (SRNE) at ...

1280 × 720
Sorrento Therapeutics ...

Sorrento Therapeutics ...

2121 × 1414
Sorrento Therapeutics 478% Upside ...

Sorrento Therapeutics 478% Upside ...

1200 × 1240
New Airbnb IPO Filing Reveals a 32 ...

New Airbnb IPO Filing Reveals a 32 ...

1634 × 799
3 “Strong Buy” Biotech Stocks That Can ...

3 “Strong Buy” Biotech Stocks That Can ...

1215 × 677
Coronavirus Outbreak A Pandemic

Coronavirus Outbreak A Pandemic

1024 × 768
SRNE Bollinger Bands

SRNE Bollinger Bands

1240 × 715
New Airbnb IPO Filing Reveals a 32 ...

New Airbnb IPO Filing Reveals a 32 ...

1634 × 799
3 “Strong Buy” Biotech Stocks That Can ...

3 “Strong Buy” Biotech Stocks That Can ...

1215 × 677
Why DEXUS, Magellan, Mesoblast, & SEEK ...

Why DEXUS, Magellan, Mesoblast, & SEEK ...

2560 × 1440
3 “Strong Buy” Biotech Stocks That Can ...

3 “Strong Buy” Biotech Stocks That Can ...

1215 × 677
3 “Strong Buy” Biotech Stocks That Can ...

3 “Strong Buy” Biotech Stocks That Can ...

1215 × 677
Abbott's Pending Loss Ushers In Ongoing ...

Abbott's Pending Loss Ushers In Ongoing ...

1580 × 1168
Abbott Laboratories Stock Forecast: up ...

Abbott Laboratories Stock Forecast: up ...

900 × 900
Stock of tiny SPI Energy skyrockets 3 ...

Stock of tiny SPI Energy skyrockets 3 ...

1320 × 742
Sorrento Therapeutics stock (SRNE) at .... Sorrento Therapeutics .... Sorrento Therapeutics 478% Upside .... New Airbnb IPO Filing Reveals a 32 .... 3 “Strong Buy” Biotech Stocks That Can .... Coronavirus Outbreak A Pandemic. SRNE Bollinger Bands. New Airbnb IPO Filing Reveals a 32 .... 3 “Strong Buy” Biotech Stocks That Can .... Why DEXUS, Magellan, Mesoblast, & SEEK .... 3 “Strong Buy” Biotech Stocks That Can .... 3 “Strong Buy” Biotech Stocks That Can .... Abbott's Pending Loss Ushers In Ongoing .... Abbott Laboratories Stock Forecast: up .... Stock of tiny SPI Energy skyrockets 3 ....